 "Unichem Lab dips on disappointing Q2 results")
Unichem Laboratories has dipped 8% to Rs 204 after reporting a 38% year on year (yoy) declined in net profit at Rs 22.30 crore for the quarter ended September 2014, due lower growth in operational income and higher raw material cost. The pharmaceutical company had profit of Rs 36.20 crore during the same quarter last fiscal.
Net sales of the company grew marginally by 3% at Rs 275 crore on yoy basis. However, the raw material cost increased by 24% yoy to Rs 84 crore during the recently concluded quarter.
The stock opened at Rs 219 and touched a low of Rs 196 on NSE. A combined 153,198 shares changed hands on the counter so far on NSE and BSE.
Net sales of the company grew marginally by 3% at Rs 275 crore on yoy basis. However, the raw material cost increased by 24% yoy to Rs 84 crore during the recently concluded quarter.
The stock opened at Rs 219 and touched a low of Rs 196 on NSE. A combined 153,198 shares changed hands on the counter so far on NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%